title: [Vaccination against acute otitis media].
abstract: Acute otitis media (AOM) is the most frequent bacterial infection in childhood. Because of the high morbidity, the costs of AOM and growing concern about increasing resistance of pneumococci, the most common bacterial cause of AOM, prevention of AOM is important. Vaccination with the recently developed pneumococcal conjugate vaccines leads to a reduction in the number of AOM cases caused by the serotypes present in the vaccine, but the reduction in overall AOM incidence is below 10%. In particular the children with recurrent episodes of AOM may benefit more from these pneumococcal conjugate vaccines.
authors.affiliation: Spaarne Ziekenhuis, afd. Kindergeneeskunde, BR Haarlem.
authors.forename: R H
authors.initials: RH
authors.lastname: Veenhoven
authors.forename: Y L
authors.initials: YL
authors.lastname: van den Berg
authors.forename: A G
authors.initials: AG
authors.lastname: Schilder
authors.forename: I J
authors.initials: IJ
authors.lastname: Dhooge
authors.forename: G T
authors.initials: GT
authors.lastname: Rijkers
authors.forename: E A
authors.initials: EA
authors.lastname: Sanders
mesh_terms: D000208:Acute Disease; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D009426:Netherlands / Q000453:epidemiology; D010033:Otitis Media / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control*; D011008:Pneumococcal Infections / Q000150:complications / Q000382:microbiology / Q000517:prevention & control*; D055502:Secondary Prevention; D013296:Streptococcus pneumoniae / Q000302:isolation & purification* / Q000472:pathogenicity; D017778:Vaccines, Combined / Q000627:therapeutic use
chemical_list: D001428:Bacterial Vaccines; D017778:Vaccines, Combined